Market Cap
S$3.50 Billion
SGD as of Jan. 1, 2026
US$2.72 Billion
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
AstraZeneca
|
$284.38 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
UnitedHealth Group
|
$304.72 B |
Singapore
languages
Healthcare
languages
Drug Manufacturers—General
Singapore Healthcare
Singapore Drug Manufacturers—General
Haw Par Corp Ltd has the following listings and related stock indices.
Stock: SGX: H02
Stock: OTC: HAWPY
Stock: OTC: HAWPF
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.